Beranda › Sindrom Bronkiolitis Obliterans › Massachusetts › Boston
Uji klinis Sindrom Bronkiolitis Obliterans di Boston, MA
13 studi untuk Sindrom Bronkiolitis Obliterans mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Menerima pesertaFase 2
- Dana-Farber Cancer Institute, Boston
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Menerima pesertaFase 2
- Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Menerima pesertaFase 2
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Menerima pesertaFase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Menerima pesertaStudi observasional
- Massachusetts Cancer Research Center, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
Menerima pesertaFase 1
- Dana-Farber Cancer Institute, Boston
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
Menerima pesertaStudi observasional
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Menerima pesertaFase 2
- Massachusetts General Hospital, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Menerima pesertaFase 2
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Menerima pesertaFase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Menerima peserta
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Menerima pesertaFase 2
- Dana-Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Menerima pesertaFase 1
- Dana-Farber Cancer Institute, Boston
Uji klinis Sindrom Bronkiolitis Obliterans di kota lain
- Seattle, WA11 studi
- Atlanta, GA10 studi
- New York City, NY9 studi
- Houston, TX8 studi
- Los Angeles, CA7 studi
- Miami, FL7 studi
- Durham, NC6 studi
- Tampa, FL6 studi
- Baldwin Park, CA6 studi
- Philadelphia, PA6 studi
- Washington, DC6 studi
- San Francisco, CA5 studi
Studi lain di Boston
- Kanker Payudara112 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)85 studi
- Kanker Metastatik63 studi
- Kanker Kolorektal63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.